IMVT Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 3.00%

Insider Buying (Last 12 Months): $2,616,202.00

Insider Selling (Last 12 Months): $1,727,999.12

Immunovant Insider Trading History Chart

Immunovant Share Price & Price History

^$17.75

▼ -0.54 (-2.95%)

As of 02/3/2023 10:04 PM ET

Days: 30 | 90 | 365

Cash Holders STILL Aren't Taking Steps to Prepare

From Investor Place Media | Ad

Stocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.

Click Here to Learn More

Immunovant Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/2/2023	William L. Macias	Insider	Sell	537	$18.24	$9,794.88	262,996
1/26/2023	Mark S Levine	Insider	Sell	10,156	$18.51	$187,987.56	245,660
1/11/2023	Eva Renee Barnett	CFO	Sell	4,510	$16.75	$75,542.50	268,347
1/11/2023	Julia G Butchko	Insider	Sell	60,490	$16.79	$1,015,627.10	331,419
1/11/2023	Peter Salzmann	CEO	Sell	4,021	$16.80	$67,552.80	993,932
10/21/2022	William L. Macias	Insider	Sell	341	$9.67	$3,297.47	308,101
10/13/2022	Julia G Butchko	Insider	Sell	928	$9.18	$8,519.04	391,909
10/13/2022	Peter Salzmann	CEO	Sell	2,793	$9.18	$25,639.74	997,953
10/11/2022	Eva Renee Barnett	CFO	Sell	12,500	$9.44	$118,000.00	272,857
10/6/2022	Sciences Ltd. Roivant	Major Shareholder	Buy	416,667	$6.00	$2,500,002.00	73,805,331
9/29/2022	Frank Torti	Director	Buy	20,000	$5.81	$116,200.00	393,358
9/28/2022	Julia G Butchko	Insider	Sell	535	$4.67	$2,498.45	392,837
9/28/2022	Peter Salzmann	CEO	Sell	1,605	$4.67	$7,495.35	1,000,746
8/30/2022	Julia G Butchko	Insider	Sell	548	$5.83	$3,194.84	393,372
8/30/2022	Peter Salzmann	CEO	Sell	1,644	$5.83	$9,584.52	1,002,351
7/27/2022	Julia G Butchko	Insider	Sell	510	$4.27	$2,177.70	281,104
7/27/2022	Peter Salzmann	CEO	Sell	1,528	$4.27	$6,524.56	552,731
7/22/2022	William L. Macias	Insider	Sell	322	$4.70	$1,513.40	195,626
6/29/2022	Julia G Butchko	Insider	Sell	460	$4.02	$1,849.20	281,614
6/29/2022	Peter Salzmann	CEO	Sell	1,376	$4.02	$5,531.52	554,259
5/24/2022	Julia G Butchko	Insider	Sell	492	$3.79	$1,864.68	282,074
5/24/2022	Peter Salzmann	CEO	Sell	1,471	$3.79	$5,575.09	555,635
4/27/2022	Julia G Butchko	Insider	Sell	541	$4.72	$2,553.52	282,566
4/27/2022	Peter Salzmann	CEO	Sell	1,622	$4.72	$7,655.84	557,106
4/19/2022	William L. Macias	Insider	Sell	1,392	$4.98	$6,932.16	195,948
3/24/2022	Julia G Butchko	Insider	Sell	6,381	$5.90	$37,647.90	283,107
3/24/2022	Peter Salzmann	CEO	Sell	19,227	$5.90	$113,439.30	558,728
1/5/2022	William L. Macias	Insider	Sell	26,813	$8.28	$222,011.64
8/27/2021	Douglas J. Hughes	Director	Buy	18,247	$8.24	$150,355.28
8/20/2021	George V. Migausky	Director	Buy	7,000	$7.65	$53,550.00
8/13/2021	Atul Pande	Director	Buy	5,000	$7.98	$39,900.00
9/11/2020	Julia G Butchko	Insider	Buy	5,000	$38.17	$190,850.00	5,000
9/4/2020	Sciences Ltd. Roivant	Major Shareholder	Buy	380,000	$33.00	$12,540,000.00	47,593,419

Know Your Profit Potential BEFORE You Trade!

From Tradewins | Ad

Click Here to Learn More

SEC Filings (Institutional Ownership Changes) for Immunovant (NASDAQ:IMVT)

32.77% of Immunovant stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Immunovant Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/2/2023	SG Americas Securities LLC	21,027	$0.37M	0.0%	+25.9%	0.016%
2/2/2023	Bailard Inc.	12,200	$0.22M	0.0%	N/A	0.009%
2/2/2023	ProShare Advisors LLC	16,409	$0.29M	0.0%	+15.4%	0.013%
2/2/2023	Concorde Asset Management LLC	16,725	$0.30M	0.3%	N/A	0.013%
2/1/2023	Zurcher Kantonalbank Zurich Cantonalbank	7,292	$0.13M	0.0%	-9.7%	0.006%
1/26/2023	Strs Ohio	36,000	$0.64M	0.0%	+32.8%	0.028%
1/24/2023	Sigma Planning Corp	55,400	$0.98M	0.0%	N/A	0.043%
1/23/2023	Allspring Global Investments Holdings LLC	13,283	$0.24M	0.0%	-65.6%	0.010%
1/20/2023	Values First Advisors Inc.	11,846	$0.21M	0.1%	-49.0%	0.009%
1/12/2023	Hennion & Walsh Asset Management Inc.	253,636	$4.50M	0.3%	+10.4%	0.196%
12/8/2022	Bank of New York Mellon Corp	149,674	$0.84M	0.0%	+5.8%	0.116%
12/2/2022	Values First Advisors Inc.	23,245	$0.13M	0.1%	+3.4%	0.018%
11/16/2022	Balyasny Asset Management LLC	153,503	$0.86M	0.0%	N/A	0.119%
11/16/2022	Jane Street Group LLC	16,106	$90K	0.0%	N/A	0.012%
11/15/2022	Alliancebernstein L.P.	86,000	$0.48M	0.0%	+2.9%	0.067%
11/15/2022	State Street Corp	878,601	$4.90M	0.0%	-1.6%	0.680%
11/15/2022	Algert Global LLC	82,741	$0.46M	0.0%	-34.4%	0.064%
11/15/2022	Two Sigma Advisers LP	341,300	$1.90M	0.0%	-36.8%	0.264%
11/15/2022	Two Sigma Investments LP	258,567	$1.44M	0.0%	-53.0%	0.200%
11/15/2022	UBS Asset Management Americas Inc.	37,345	$0.21M	0.0%	-28.1%	0.029%
11/15/2022	Vanguard Group Inc.	4,000,450	$22.32M	0.0%	+0.0%	3.097%
11/15/2022	Platinum Investment Management Ltd.	659,075	$3.68M	0.2%	-15.2%	0.510%
11/15/2022	Ensign Peak Advisors Inc	6,350	$35K	0.0%	+72.6%	0.005%
11/15/2022	Federated Hermes Inc.	9,860	$55K	0.0%	-99.5%	0.008%
11/15/2022	Bank of New York Mellon Corp	149,674	$0.84M	0.0%	+5.8%	0.116%
11/15/2022	BlackRock Inc.	3,506,674	$19.57M	0.0%	-3.4%	2.715%
11/15/2022	Cantor Fitzgerald L. P.	94,400	$0.53M	0.0%	N/A	0.073%
11/14/2022	Point72 Asset Management L.P.	1,967,300	$10.98M	0.0%	N/A	1.523%
11/14/2022	Cubist Systematic Strategies LLC	34,431	$0.19M	0.0%	+22.2%	0.027%
11/14/2022	PDT Partners LLC	12,195	$68K	0.0%	-91.0%	0.009%
11/14/2022	Renaissance Technologies LLC	352,500	$1.97M	0.0%	+6.0%	0.273%
11/14/2022	Boothbay Fund Management LLC	142,135	$0.79M	0.0%	N/A	0.110%
11/14/2022	Ergoteles LLC	12,400	$69K	0.0%	-16.9%	0.010%
11/14/2022	Nuveen Asset Management LLC	178,428	$1M	0.0%	-1.7%	0.138%
11/14/2022	MetLife Investment Management LLC	21,647	$0.12M	0.0%	N/A	0.017%
11/14/2022	Hsbc Holdings PLC	129,289	$0.71M	0.0%	+5.6%	0.100%
11/14/2022	Hennion & Walsh Asset Management Inc.	229,675	$1.28M	0.1%	-2.7%	0.178%
11/10/2022	Credit Suisse AG	40,279	$0.23M	0.0%	+8.8%	0.031%
11/10/2022	Connor Clark & Lunn Investment Management Ltd.	18,352	$0.10M	0.0%	N/A	0.014%
11/10/2022	ExodusPoint Capital Management LP	22,776	$0.13M	0.0%	-92.7%	0.018%
11/10/2022	Dimensional Fund Advisors LP	1,058,459	$5.91M	0.0%	+11.9%	0.819%
11/10/2022	Tower Research Capital LLC TRC	11,683	$65K	0.0%	+102.8%	0.009%
11/10/2022	UBS Group AG	6,978	$39K	0.0%	+205.7%	0.005%
11/7/2022	Nisa Investment Advisors LLC	5,800	$59K	0.0%	+20.8%	0.005%
11/4/2022	Prudential Financial Inc.	116,380	$0.65M	0.0%	N/A	0.100%
11/3/2022	Teacher Retirement System of Texas	13,283	$74K	0.0%	N/A	0.011%
11/3/2022	Barclays PLC	6,000	$33K	0.0%	N/A	0.005%
10/31/2022	SG Americas Securities LLC	16,704	$93K	0.0%	-26.2%	0.014%
10/28/2022	Silverarc Capital Management LLC	300,000	$1.67M	0.6%	N/A	0.257%
10/27/2022	Prospera Financial Services Inc	10,777	$60K	0.0%	N/A	0.009%
10/26/2022	Allspring Global Investments Holdings LLC	38,667	$0.22M	0.0%	-21.3%	0.033%
9/16/2022	Federated Hermes Inc.	1,882,351	$7.34M	0.0%	-1.1%	1.615%
8/22/2022	ExodusPoint Capital Management LP	313,356	$1.22M	0.0%	+5.1%	0.269%
8/18/2022	Goldman Sachs Group Inc.	244,952	$0.96M	0.0%	-31.1%	0.210%
8/16/2022	Woodline Partners LP	92,100	$0.36M	0.0%	N/A	0.079%
8/16/2022	International Biotechnology Trust PLC	233	$60K	0.6%	-99.6%	0.000%
8/15/2022	State Street Corp	892,680	$3.48M	0.0%	+6.8%	0.766%
8/15/2022	Cubist Systematic Strategies LLC	28,167	$0.11M	0.0%	-29.5%	0.024%
8/15/2022	Millennium Management LLC	333,553	$1.30M	0.0%	-44.1%	0.286%
8/13/2022	Renaissance Technologies LLC	332,600	$1.30M	0.0%	+230.3%	0.285%
8/12/2022	Northern Trust Corp	357,241	$1.39M	0.0%	-3.1%	0.306%
8/12/2022	Virtus ETF Advisers LLC	30,146	$0.12M	0.0%	+42.5%	0.026%
8/12/2022	Credit Suisse AG	37,013	$0.15M	0.0%	+6.1%	0.032%
8/12/2022	Rhumbline Advisers	58,175	$0.23M	0.0%	+28.0%	0.050%
8/11/2022	Platinum Investment Management Ltd.	777,590	$3.03M	0.1%	+13.2%	0.667%
8/11/2022	Alps Advisors Inc.	69,110	$0.27M	0.0%	-42.2%	0.059%
8/11/2022	JPMorgan Chase & Co.	653,181	$2.55M	0.0%	+41.5%	0.560%
8/10/2022	Principal Financial Group Inc.	15,327	$60K	0.0%	+17.6%	0.013%
8/1/2022	ProShare Advisors LLC	13,564	$53K	0.0%	-31.0%	0.012%
7/29/2022	SG Americas Securities LLC	22,622	$88K	0.0%	N/A	0.019%
7/26/2022	Mirae Asset Global Investments Co. Ltd.	14,532	$57K	0.0%	N/A	0.012%
7/26/2022	Dupont Capital Management Corp	34,088	$0.13M	0.0%	+36.2%	0.029%
7/25/2022	Allspring Global Investments Holdings LLC	49,161	$0.19M	0.0%	N/A	0.042%
7/20/2022	Values First Advisors Inc.	22,482	$88K	0.1%	+66.9%	0.019%
7/19/2022	Hennion & Walsh Asset Management Inc.	235,997	$0.92M	0.1%	+6.7%	0.203%
6/30/2022	Amalgamated Bank	5,943	$33K	0.0%	N/A	0.005%
6/7/2022	Bank of America Corp DE	26,167	$0.14M	0.0%	-88.4%	0.022%
5/17/2022	Virtu Financial LLC	21,250	$0.12M	0.0%	+42.5%	0.018%
5/17/2022	Jane Street Group LLC	41,178	$0.23M	0.0%	-59.8%	0.035%
5/17/2022	Eventide Asset Management LLC	5,372,512	$29.60M	0.5%	+8.5%	4.616%
5/16/2022	California State Teachers Retirement System	51,445	$0.28M	0.0%	-7.0%	0.044%
5/16/2022	Goldman Sachs Group Inc.	355,694	$1.96M	0.0%	+21.0%	0.306%
5/16/2022	PDT Partners LLC	135,228	$0.75M	0.1%	+23.9%	0.116%
5/16/2022	Deep Track Capital LP	7,224,613	$39.81M	2.6%	+51.3%	6.207%
5/16/2022	State Street Corp	835,742	$4.61M	0.0%	-70.0%	0.718%
5/16/2022	Frazier Life Sciences Management L.P.	585,759	$3.23M	0.3%	N/A	0.503%
5/16/2022	Hsbc Holdings PLC	109,939	$0.62M	0.0%	+4.6%	0.094%
5/13/2022	Renaissance Technologies LLC	100,700	$0.56M	0.0%	+472.2%	0.087%
5/13/2022	Northern Trust Corp	368,486	$2.03M	0.0%	-5.4%	0.317%
5/13/2022	Charles Schwab Investment Management Inc.	298,115	$1.64M	0.0%	+2.5%	0.256%
5/13/2022	Federated Hermes Inc.	1,903,894	$10.49M	0.0%	+281.2%	1.636%
5/13/2022	Bridgefront Capital LLC	19,002	$0.11M	0.1%	N/A	0.016%
5/13/2022	Vanguard Group Inc.	3,765,713	$20.75M	0.0%	-1.8%	3.235%
5/13/2022	Platinum Investment Management Ltd.	686,660	$3.78M	0.1%	+11.5%	0.590%
5/13/2022	Dimensional Fund Advisors LP	690,965	$3.81M	0.0%	+148.6%	0.594%
5/12/2022	BlackRock Inc.	3,353,866	$18.48M	0.0%	+0.9%	2.881%
5/12/2022	MetLife Investment Management LLC	25,184	$0.14M	0.0%	+423.9%	0.022%
5/12/2022	Martingale Asset Management L P	70,051	$0.39M	0.0%	+13.3%	0.060%
5/12/2022	Healthcare of Ontario Pension Plan Trust Fund	93,300	$0.51M	0.0%	-24.9%	0.080%
5/12/2022	Citigroup Inc.	5,322	$29K	0.0%	-96.6%	0.005%

Data available starting January 2016

Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of myasthenia gravis and thyroid eye disease, as well as completed initiation of Phase II clinical trials for the treatment of warm autoimmune hemolytic anemia. The company was incorporated in 2018 is headquartered in New York, New York. Immunovant, Inc. is a subsidiary of Roivant Sciences Ltd.

Today's Range

Now: $17.75

$15.31

$19.09

50 Day Range

MA: $16.74

$12.70

$19.72

52 Week Range

Now: $17.75

$3.14

$20.24

Volume

1,249,300 shs

Average Volume

1,305,457 shs

Market Capitalization

$2.29 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

Who are the company insiders with the largest holdings of Immunovant?: Immunovant's top insider shareholders include:
Sciences Ltd Roivant (Major Shareholder)
Peter Salzmann (CEO)
Julia G Butchko (Insider)
Frank Torti (Director)
William L Macias (Insider)
Eva Renee Barnett (CFO)
Mark S Levine (Insider)
Atul Pande (Director)
Douglas J Hughes (Director)
George V Migausky (Director)
Learn More about top insider investors at Immunovant.
Who are the major institutional investors of Immunovant?: Immunovant's top institutional investors include:
Hennion & Walsh Asset Management Inc. — 0.20%
Sigma Planning Corp — 0.04%
Strs Ohio — 0.03%
SG Americas Securities LLC — 0.02%
Concorde Asset Management LLC — 0.01%
ProShare Advisors LLC — 0.01%
Learn More about top institutional investors of Immunovant stock.
Which institutional investors are selling Immunovant stock?: During the previous quarter, IMVT stock was sold by these institutional investors:
Allspring Global Investments Holdings LLC
Values First Advisors Inc.
Simplex Trading LLC
Zurcher Kantonalbank Zurich Cantonalbank
Within the last year, company insiders that have sold Immunovant company stock include:
Sciences Ltd Roivant (Major Shareholder)
Peter Salzmann (CEO)
Julia G Butchko (Insider)
Frank Torti (Director)
William L Macias (Insider)
Learn More investors selling Immunovant stock.
Which institutional investors are buying Immunovant stock?: Within the previous quarter, IMVT stock was bought by institutional investors including:
Sigma Planning Corp
Hennion & Walsh Asset Management Inc.
Concorde Asset Management LLC
Bailard Inc.
Strs Ohio
SG Americas Securities LLC
ProShare Advisors LLC
Within the previous year, these company insiders have bought Immunovant stock:
Sciences Ltd Roivant (Major Shareholder)
Peter Salzmann (CEO)
Julia G Butchko (Insider)
Frank Torti (Director)
William L Macias (Insider)
Learn More investors buying Immunovant stock.